Saturday, June 13, 2026
ADVT 
National

Talks On Future Of BC's Child Support Clawback Program To Start Dec. 10

The Canadian Press , 18 Nov, 2014 02:35 PM
    VICTORIA — Social Development Minister Don McRae says he'll start talks next month on the future of the government's so-called support-payment clawback program.
     
    The program kicks in when families on government assistance receive court-ordered child support payments, and as a result welfare or disability payments are cut so overall monthly payments don't exceed the government limits.
     
    The consultations were scheduled to start last week, but McRae apologized on Tuesday for their abrupt postponement.
     
    "In June 2104, I committed to having a dialogue going forward, and on Dec. 10, which is in the fall, we will begin it."
     
    McRae's announcement came as the Opposition New Democrats and about a dozen people appeared at the legislature to push for immediate removal of the program.
     
    McRae said the consultations are part of the government's evolving goals to help British Columbia's most vulnerable citizens become self-supporting.
     
    "The work is not done yet." he said. "We will continue it."
     
    Nelson-Creston New Democrat Michelle Mungall said the clawback creates a hardship for many families receiving social assistance or disability payments.
     
    "No one, no one believes the minister when he says he can't afford to give B.C.'s poorest kids their money back," she said.
     
    The government's all-party finance committee recommended a review of the program in its annual report to the Finance Ministry.

    MORE National ARTICLES

    Tekmira in talks about using experimental Ebola drug in infected patients

    Tekmira in talks about using experimental Ebola drug in infected patients
    VANCOUVER - Tekmira Pharmaceuticals Corp. (TSX:TKM) is in discussions about making its experimental Ebola drug available to infected patients, but says there is no guarantee the treatment can be used to help quell the outbreak in West Africa.

    Tekmira in talks about using experimental Ebola drug in infected patients

    Vancouver police officer used too much force during traffic stop: watchdog

    Vancouver police officer used too much force during traffic stop: watchdog
    A Vancouver police officer used excessive and unnecessary force when he punched a driver three times during a traffic stop in 2012, said a ruling by B.C.'s police watchdog.

    Vancouver police officer used too much force during traffic stop: watchdog

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto
    A Calgary company is looking to boost the profile of the world's newest, and most controversial, currency with the launch of six more teller machines in Toronto that deal in the virtual currency Bitcoin.

    Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

    White House talking to Canada, others about aiding Iraqi refugees

    White House talking to Canada, others about aiding Iraqi refugees
    The United States is considering a multinational mission to whisk displaced people to safety in Iraq and it appears there may be a supporting role for Canada.

    White House talking to Canada, others about aiding Iraqi refugees

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful
    A special prosecutor has approved polygamy charges against the two leaders of an isolated religious sect in southeastern British Columbia.

    B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

    Ebola drug developer Tekmira's net loss widens during second quarter

    Ebola drug developer Tekmira's net loss widens during second quarter
    Tekmira Pharmaceuticals Corp. (TSX:TKM) says it's in talks with governments and non-governmental organizations in various countries about the potential use of its experimental Ebola drug in infected patients.

    Ebola drug developer Tekmira's net loss widens during second quarter